Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Takeshi Yamashita, Thomas Laurent, Masaharu Kato, Nariaki Yoshihara & Fumiko Ono. (2020) Comparison of hospital length of stay of acute ischemic stroke patients with non-valvular atrial fibrillation started on rivaroxaban or warfarin treatment during hospitalization. Journal of Medical Economics 23:12, pages 1379-1388.
Read now
Read now
Alpesh Amin, Allison Keshishian, Lien Vo, Qisu Zhang, Oluwaseyi Dina, Chad Patel, Kevin Odell & Jeffrey Trocio. (2018) Real-world comparison of all-cause hospitalizations, hospitalizations due to stroke and major bleeding, and costs for non-valvular atrial fibrillation patients prescribed oral anticoagulants in a US health plan. Journal of Medical Economics 21:3, pages 244-253.
Read now
Read now
Lin Xie, Lien Vo, Allison Keshishian, Kwanza Price, Prianka Singh, Jack Mardekian, Amanda Bruno, Onur Baser, Jully Kim, Wilson Tan & Jeffrey Trocio. (2016) Comparison of hospital length of stay and hospitalization costs among patients with non-valvular atrial fibrillation treated with apixaban or warfarin: An early view. Journal of Medical Economics 19:8, pages 769-776.
Read now
Read now
Articles from other publishers (10)
Jingchuan Serena GuoMeiqi HeNico GabrielJared W MagnaniStephen E KimmelWalid F GelladInmaculada Hernandez. (2022) Underprescribing vs underfilling to oral anticoagulation: An analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillation. Journal of Managed Care & Specialty Pharmacy 28:12, pages 1400-1409.
Crossref
Crossref
Ancuța Elena Vîjan, Ioana Cristina Daha, Caterina Delcea & Gheorghe-Andrei Dan. (2021) Determinants of Prolonged Length of Hospital Stay of Patients with Atrial Fibrillation. Journal of Clinical Medicine 10:16, pages 3715.
Crossref
Crossref
Alpesh AminAllison KeshishianJeffrey TrocioOluwaseyi DinaHannah LeLisa RosenblattXianchen LiuJack MardekianQisu ZhangOnur BaserAnagha NadkarniLien Vo. (2020) A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population. Journal of Managed Care & Specialty Pharmacy 26:5, pages 639-651.
Crossref
Crossref
Anne Holbrook, Richard Morrow, Agnes Y. Y. Lee, Gary Foster & Eleanor Pullenyegum. (2020) Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation: A retrospective cohort study. Journal of Population Therapeutics & Clinical Pharmacology 27:2, pages e32-e55.
Crossref
Crossref
Tomohide Akase, Takanori Tsuchiya & Masami Morita. (2019) Hospitalization period and direct medical cost in patients using warfarin or novel oral anti‐coagulants after a cerebral embolism. International Journal of Clinical Pharmacy 41:2, pages 546-554.
Crossref
Crossref
Alpesh AminAllison KeshishianJeffrey TrocioOluwaseyi DinaHannah LeLisa RosenblattXianchen LiuJack MardekianQisu ZhangOnur BaserAnagha NadkarniLien Vo. (2018) A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population. Journal of Managed Care & Specialty Pharmacy 24:9, pages 911-920.
Crossref
Crossref
Lara M. Groetzinger, Taylor J. Miller, Ryan M. Rivosecchi, Roy E. Smith, Mark T. Gladwin & Belinda N. Rivera-Lebron. (2018) Apixaban or Rivaroxaban Versus Warfarin for Treatment of Submassive Pulmonary Embolism After Catheter-Directed Thrombolysis. Clinical and Applied Thrombosis/Hemostasis 24:6, pages 908-913.
Crossref
Crossref
Catherine A Saint, Michelle R Castelli, Andrew J Crannage, Zachary A Stacy & Erin K Hennessey. (2017) Comparison of hospital length of stay in patients treated with non–vitamin K oral anticoagulants or parenteral agents plus warfarin for venous thromboembolism. SAGE Open Medicine 5, pages 205031211771962.
Crossref
Crossref
Steven DeitelzweigXuemei LuoKiran GuptaJeffrey TrocioJack MardekianTammy CurticeMelissa Lingohr-SmithBrandy MengesJay Lin. (2017) Effect of Apixaban Versus Warfarin Use on Health Care Resource Utilization and Costs Among Elderly Patients with Nonvalvular Atrial Fibrillation. Journal of Managed Care & Specialty Pharmacy 23:11, pages 1191-1201.
Crossref
Crossref
Christopher J. Boos & Louise Brown. (2016) Anticoagulation in atrial fibrillation and chronic heart failure. Current Opinion in Cardiology 31:2, pages 229-234.
Crossref
Crossref